Pancreatic Cancer Research

ResearcherUniversity of MichiganNo recent work listed

Xiaohua Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4308-6126; OpenAlex author ID A5085886216. Sources: OpenAlex.

Their work

Papers
8 (first author 6, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 8

  1. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context. Co-author DOI 10.7554/elife.73245↗
  2. The inhibition of cell proliferation and induction of apoptosis in pancreatic ductal adenocarcinoma cells by verrucarin A, a macrocyclic trichothecene, is asso… First author DOI 10.3892/ijo.2016.3587↗
  3. CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ijo.2015.3212↗
  4. Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells. First author DOI 10.3892/or.2015.3989↗
  5. Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling protei… First author DOI 10.3892/ijo.2014.2325↗
  6. Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent. First author DOI 10.3390/molecules18033250↗
  7. Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of… First author DOI 10.1016/j.bbrc.2012.05.024↗
  8. Inhibition of cell proliferation and induction of apoptosis by CDDO-Me in pancreatic cancer cells is ROS-dependent. First author PMID 22946344↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dorrah Deeb · 7 shared papers, 2012–2016 · strength 0.36
  2. Subhash C. Gautam · 7 shared papers, 2012–2016 · strength 0.36
  3. Christopher J. Halbrook · 1 shared paper, 2022 · strength 0.10
  4. Samantha B. Kemp · 1 shared paper, 2022 · strength 0.10
  5. Nina G. Steele · 1 shared paper, 2022 · strength 0.10
  6. Zeribe C. Nwosu · 1 shared paper, 2022 · strength 0.10
  7. David R Piwnica-Worms · 1 shared paper, 2022 · strength 0.10
  8. David B. Lombard · 1 shared paper, 2022 · strength 0.10
  9. Megan T. Hoffman · 1 shared paper, 2022 · strength 0.10
  10. Yaqing Zhang · 1 shared paper, 2022 · strength 0.10
  11. Marina Pasca di Magliano · 1 shared paper, 2022 · strength 0.10
  12. Haoqiang Ying · 1 shared paper, 2022 · strength 0.10
  13. Samuel Andrew Kerk · 1 shared paper, 2022 · strength 0.10
  14. Li Zhang · 1 shared paper, 2022 · strength 0.10
  15. Costas Andreas Lyssiotis · 1 shared paper, 2022 · strength 0.10
  16. Howard C. Crawford · 1 shared paper, 2022 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.